143 related articles for article (PubMed ID: 37898347)
1. Reply to: "Liver-adipose tissue crosstalk in nonalcoholic fatty liver disease: the emerging role of remnant cholesterol": "BAT activation might improve NAFLD in patients, but this might require developing and/or maintaining functionally relevant levels of BAT mass.".
Lee E; Korf H; Vidal-Puig A
J Hepatol; 2024 Mar; 80(3):e112-e114. PubMed ID: 37898347
[No Abstract] [Full Text] [Related]
2. Liver-adipose tissue crosstalk in non-alcoholic fatty liver disease: The emerging role of remnant cholesterol.
Liu Y; Chen M
J Hepatol; 2024 Mar; 80(3):e111-e112. PubMed ID: 37380106
[No Abstract] [Full Text] [Related]
3. Recent Advances in Adipose Tissue Dysfunction and Its Role in the Pathogenesis of Non-Alcoholic Fatty Liver Disease.
Wang X; Rao H; Liu F; Wei L; Li H; Wu C
Cells; 2021 Nov; 10(12):. PubMed ID: 34943809
[TBL] [Abstract][Full Text] [Related]
4. Crosstalk between adipose tissue insulin resistance and liver macrophages in non-alcoholic fatty liver disease.
Rosso C; Kazankov K; Younes R; Esmaili S; Marietti M; Sacco M; Carli F; Gaggini M; Salomone F; Møller HJ; Abate ML; Vilstrup H; Gastaldelli A; George J; Grønbæk H; Bugianesi E
J Hepatol; 2019 Nov; 71(5):1012-1021. PubMed ID: 31301321
[TBL] [Abstract][Full Text] [Related]
5. Remnant Cholesterol Independently Predicts the Development of Nonalcoholic Fatty Liver Disease.
Huang H; Xie J; Zeng Y; Liu Z; Miao M; Xu L; Xu C
J Clin Endocrinol Metab; 2023 Oct; 108(11):2907-2915. PubMed ID: 37186667
[TBL] [Abstract][Full Text] [Related]
6. Macrophages as Key Players during Adipose Tissue-Liver Crosstalk in Nonalcoholic Fatty Liver Disease.
Korf H; Boesch M; Meelberghs L; van der Merwe S
Semin Liver Dis; 2019 Jul; 39(3):291-300. PubMed ID: 31041786
[TBL] [Abstract][Full Text] [Related]
7. Remnant cholesterol, stronger than triglycerides, is associated with incident non-alcoholic fatty liver disease.
Cheng Y; Zhang Q; Li H; Zhou G; Shi P; Zhang X; Guan L; Yan F; Xu C
Front Endocrinol (Lausanne); 2023; 14():1098078. PubMed ID: 37214248
[TBL] [Abstract][Full Text] [Related]
8. Effect of adipose tissue insulin resistance on metabolic parameters and liver histology in obese patients with nonalcoholic fatty liver disease.
Lomonaco R; Ortiz-Lopez C; Orsak B; Webb A; Hardies J; Darland C; Finch J; Gastaldelli A; Harrison S; Tio F; Cusi K
Hepatology; 2012 May; 55(5):1389-97. PubMed ID: 22183689
[TBL] [Abstract][Full Text] [Related]
9. Not only baseline but cumulative exposure of remnant cholesterol predicts the development of nonalcoholic fatty liver disease: a cohort study.
Liu L; Wang C; Hu Z; Deng S; Yang S; Zhu X; Deng Y; Wang Y
Environ Health Prev Med; 2024; 29():5. PubMed ID: 38325840
[TBL] [Abstract][Full Text] [Related]
10. Cyanidin-3-O-β-glucoside regulates the activation and the secretion of adipokines from brown adipose tissue and alleviates diet induced fatty liver.
Pei L; Wan T; Wang S; Ye M; Qiu Y; Jiang R; Pang N; Huang Y; Zhou Y; Jiang X; Ling W; Zhang Z; Yang L
Biomed Pharmacother; 2018 Sep; 105():625-632. PubMed ID: 29898429
[TBL] [Abstract][Full Text] [Related]
11. Association of remnant cholesterol with nonalcoholic fatty liver disease: a general population-based study.
Zou Y; Lan J; Zhong Y; Yang S; Zhang H; Xie G
Lipids Health Dis; 2021 Oct; 20(1):139. PubMed ID: 34657611
[TBL] [Abstract][Full Text] [Related]
12. Sex Differences in Nonalcoholic Fatty Liver Disease: Estrogen Influence on the Liver-Adipose Tissue Crosstalk.
Morán-Costoya A; Proenza AM; Gianotti M; Lladó I; Valle A
Antioxid Redox Signal; 2021 Sep; 35(9):753-774. PubMed ID: 33736456
[No Abstract] [Full Text] [Related]
13. Western diet-induced mouse model of non-alcoholic fatty liver disease associated with metabolic outcomes: Features of gut microbiome-liver-adipose tissue axis.
Romualdo GR; Valente LC; Sprocatti AC; Bacil GP; de Souza IP; Rodrigues J; Rodrigues MAM; Vinken M; Cogliati B; Barbisan LF
Nutrition; 2022; 103-104():111836. PubMed ID: 36202025
[TBL] [Abstract][Full Text] [Related]
14. Remnant cholesterol has a non-linear association with non-alcoholic fatty liver disease.
Chen J; Su Y; Su X; Luo F
Diabetes Res Clin Pract; 2023 Jul; 201():110733. PubMed ID: 37245725
[TBL] [Abstract][Full Text] [Related]
15. Association between the presence of brown adipose tissue and non-alcoholic fatty liver disease in adult humans.
Yilmaz Y; Ones T; Purnak T; Ozguven S; Kurt R; Atug O; Turoglu HT; Imeryuz N
Aliment Pharmacol Ther; 2011 Aug; 34(3):318-23. PubMed ID: 21631560
[TBL] [Abstract][Full Text] [Related]
16. Regulatory Networks, Management Approaches, and Emerging Treatments of Nonalcoholic Fatty Liver Disease.
Yang B; Yang X; Tan X; Lu L; Fan W; Barbier-Torres L; Steggerda J; Liu T; Yang H
Can J Gastroenterol Hepatol; 2022; 2022():6799414. PubMed ID: 36397950
[TBL] [Abstract][Full Text] [Related]
17. Nonalcoholic Fatty Liver Disease: Basic Pathogenetic Mechanisms in the Progression From NAFLD to NASH.
Pierantonelli I; Svegliati-Baroni G
Transplantation; 2019 Jan; 103(1):e1-e13. PubMed ID: 30300287
[TBL] [Abstract][Full Text] [Related]
18. Association between nonalcoholic fatty liver disease and cardiovascular risk in obese children and adolescents.
Alp H; Karaarslan S; Selver Eklioğlu B; Atabek ME; Altın H; Baysal T
Can J Cardiol; 2013 Sep; 29(9):1118-25. PubMed ID: 23040432
[TBL] [Abstract][Full Text] [Related]
19. Association between remnant lipoprotein cholesterol levels and non-alcoholic fatty liver disease in adolescents.
Chin J; Mori TA; Adams LA; Beilin LJ; Huang RC; Olynyk JK; Ayonrinde OT
JHEP Rep; 2020 Dec; 2(6):100150. PubMed ID: 32984791
[TBL] [Abstract][Full Text] [Related]
20. Modifying effects of 2,4-D and Glyphosate exposures on gut-liver-adipose tissue axis of diet-induced non-alcoholic fatty liver disease in mice.
Romualdo GR; Valente LC; de Souza JLH; Rodrigues J; Barbisan LF
Ecotoxicol Environ Saf; 2023 Dec; 268():115688. PubMed ID: 37992649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
